This content is machine translated Cardiovascular diseases New study data on primary prophylaxis with ASA: carefully weigh benefits and risks Acetylsalicylic acid (ASA) has long been established for the secondary prevention of cardiovascular events. In contrast, ASA administration for primary prevention is controversial. While European experts tend to advise against…
View Post 8 min This content is machine translated Infarct patients Medication follow-up in the family doctor’s office After acute treatment in the center hospital, the therapy of infarct patients is not complete. In addition to lifestyle changes, treatment of blood pressure, cholesterol, or any heart failure, antithrombotic…
View Post 6 min This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
